These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A randomized trial to determine the distribution of four topical gel formulations in the human vagina. Barnhart K; Kulp JL; Rosen M; Shera DM Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499 [TBL] [Abstract][Full Text] [Related]
8. Vaginal deployment and tenofovir delivery by microbicide gels. Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971 [TBL] [Abstract][Full Text] [Related]
9. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512 [TBL] [Abstract][Full Text] [Related]
10. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study. Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496 [TBL] [Abstract][Full Text] [Related]
11. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064 [TBL] [Abstract][Full Text] [Related]
12. Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels. Lai BE; Henderson MH; Peters JJ; Walmer DK; Katz DF Biophys J; 2009 Nov; 97(9):2379-87. PubMed ID: 19883580 [TBL] [Abstract][Full Text] [Related]
13. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study. Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286 [TBL] [Abstract][Full Text] [Related]
14. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein. D'Cruz OJ; Waurzyniak B; Uckun FM Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159 [TBL] [Abstract][Full Text] [Related]
15. Optical imaging and analysis of human vaginal coating by drug delivery gels. Henderson MH; Couchman GM; Walmer DK; Peters JJ; Owen DH; Brown MA; Lavine ML; Katz DF Contraception; 2007 Feb; 75(2):142-51. PubMed ID: 17241845 [TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1. Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474 [TBL] [Abstract][Full Text] [Related]
17. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen. Geonnotti AR; Peters JJ; Katz DF J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472 [TBL] [Abstract][Full Text] [Related]
18. Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models. Piret J; Laforest G; Bussières M; Bergeron MG J Appl Toxicol; 2008 Mar; 28(2):164-74. PubMed ID: 17549701 [TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? das Neves J; Amiji M; Sarmento B Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290 [TBL] [Abstract][Full Text] [Related]